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Figure S1 Illustrative plot of the binned and cut heparin-OSCS [0.25-25%] spectra. 
 
Figure S2. Reconstructed spectra of the OSCS [0.25 - 25 %] contaminant. The above spectra were created 
by subtracting the heparin 2D-COS power spectrum away from the specific OSCS [0.25 -25 %] plus heparin 
dataset power spectrum. The power spectrum is the diagonal of the 2D-COS spectrum, or the variance of 
the covariance matrix. 
 
Figure S3 Illustrative plot of the binned and cut heparin-OSDxS/OSAS [2-20%] spectra. 
 
 
Figure S4. Reconstructed spectra of the OSAS [2 - 20 %] contaminant. The above spectra were created by 
subtracting the heparin 2D-COS power spectrum away from the specific OSAS [2 - 20 %] plus heparin 
dataset power spectrum. The power spectrum is the diagonal of the 2D-COS spectrum, or the variance of 
the covariance matrix. 
 
Figure S5. Reconstructed spectra of the OSDxS [2 - 20 %] contamination. The above spectra were created 
by subtracting the heparin 2D-COS power spectrum away from the specific OSDxS [2 - 20 %] plus heparin 
dataset power spectrum. The power spectrum is the diagonal of the 2D-COS spectrum, or the variance of 
the covariance matrix. 
 
Figure S6 2D-COS analysis of unpurified GAG extract 1 (1, 5 5and 10 % (w/w)) added to a pharmaceutical 
heparin sample. Panels A (1% w/w), C (5% w/w) and E (10 w/w) show the 2D-COS spectra generated when 
the contaminants were added to the heparin library. Panels B, D and F are the difference 2D-COS spectra, 
the contaminated heparin added to the heparin library 2D-COS minus the 2D-COS spectra of the heparin 
dataset. 
 
Figure S7 2D-COS analysis of unpurified sulfated GAG extract 1 (1, 5 and 10 % (w/w)) added to a 
pharmaceutical heparin samples. Panels A (1% w/w), C (5% w/w) and E (10 w/w) show the 2D-COS spectra 
generated when the contaminants were added to the heparin library. Panels B, D and F are the difference 
2D-COS spectra, the contaminated heparin added to the heparin library 2D-COS minus the 2D-COS spectra 
of the heparin dataset. 
 
 
Figure S8 The N-acetyl region of the 2D-COS. Difference analysis of (A) unpurified GAG extract 1 (5% w/w) 
and (B) sulfated GAG extract 1 (5% w/w) added to a pharmaceutical heparin sample. The difference spectra 
were generated by subtracting the 2D-COS spectrum of the heparin reference library from the 2D-COS 
spectrum of the heparin reference library including the contaminated heparin sample. The multiple cross 
peak correlations reveal how complicated the pollutant is in this case.   
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